Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun;28(2):202-6.
doi: 10.1055/s-0031-1280665.

Nontarget embolization complicating transarterial chemoembolization in a patient with hepatocellular carcinoma

Christopher R Ingraham  1 , Guy E Johnson, Ajit V Nair, Siddharth A Padia
Affiliations

Nontarget embolization complicating transarterial chemoembolization in a patient with hepatocellular carcinoma

Christopher R Ingraham et al. Semin Intervent Radiol. 2011 Jun.

Abstract

Nontarget embolization during transarterial chemoembolization, although infrequent, can be a serious complication. The authors describe a case of nontarget gastric embolization to the stomach after transarterial chemoembolization and describe the published incidence of nontarget embolization to various organs, its diagnosis, treatment, and possible outcomes.

Keywords: Chemoembolization; hepatocellular carcinoma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Axial contrast medium-enhanced T1-weighted fat-saturated magnetic resonance image demonstrates multiple small, ill-defined, arterially enhancing lesions in the left hepatic lobe. The lesions demonstrated washout on delayed images, consistent with hepatocellular carcinoma.
Figure 2
Figure 2
Digital subtraction angiogram with a reverse-curve catheter positioned in the celiac trunk demonstrates conventional celiac artery anatomy.
Figure 3
Figure 3
Digital subtraction angiogram with a microcatheter in the proximal left hepatic artery demonstrates multiple branches off the left hepatic artery. Chemoembolization was performed at this position.
Figure 4
Figure 4
Angiogram with a microcatheter in the proper hepatic artery after chemoembolization had been performed demonstrates contrast within all hepatic branches. Additionally, there is increased density within the stomach, consistent with Ethiodol® uptake.
Figure 5
Figure 5
Noncontrast axial (A) computed tomography scans with coronal reconstruction (B) show distribution of Ethiodol®, which is present in the left hepatic lobe, caudate lobe, and the gastric rugae.
See this image and copyright information in PMC

References

    1. Cammà C, Schepis F, Orlando A, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology. 2002;224(1):47–54. - PubMed
    1. Brown D B, Fundakowski C E, Lisker-Melman M, et al. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol. 2004;15(11):1209–1218. - PubMed
    1. Gates J, Hartnell G G, Stuart K E, Clouse M E. Chemoembolization of hepatic neoplasms: safety, complications, and when to worry. Radiographics. 1999;19(2):399–414. - PubMed
    1. López-Benítez R, Radeleff B A, Barragán-Campos H M, et al. Acute pancreatitis after embolization of liver tumors: frequency and associated risk factors. Pancreatology. 2007;7(1):53–62. - PubMed
    1. Su Y C, Chen L T, Jan C M, et al. Reappraisal of gastroduodenal lesions after transcatheter arterial chemoembolization of liver neoplasms—selective versus superselective method. J Clin Gastroenterol. 1994;18(2):118–121. - PubMed